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Background/aim: Multiple zones of injuries are formed after burns, consisting of a zone of coagulative necrosis, a zone of hyperemia,
and a zone of stasis, in which progressive microcirculatory thrombosis leads to degeneration and deepening of the wound. We used an
experimental rat comb burn model to test the hypothesis that use of low molecular weight heparin (LMWH) may save the zone of stasis.
Materials and methods: Adult female rats were randomly divided two groups: the LMWH group (n = 8) rats received subcutaneous
LMWH injections, while the saline group (n = 8) rats were injected with the same volume of saline solution by the same route. The zone
of stasis was evaluated macroscopically and histologically, and functional capillary density was evaluated.
Results: Histological assessments revealed higher macrophage numbers and PML density, fibroblast proliferation, and angiogenesis
in the LMWH group than in the saline group. Functional capillary density measurement in the stasis zones revealed no significant
difference between the two groups in the first 4 days, although a significant difference in favor of the LMW group was observed in the
last 3 days.
Conclusion: The results of this experimental study show that LMWH is effective in saving the zone of stasis.
Key words: Low molecular weight heparin, burn, stasis zone

1. Introduction
Burn injuries are among the most devastating of all
traumas, a significant global public health problem, and a
cause of major morbidity and mortality worldwide. Burn
wound management therefore deserves very significant
attention. Following acute burn injury, multiple concentric
zones of injury form, as first described by Jackson in 1953
(1): the central zone of coagulation, the zone of stasis (the
intermediate zone), and the outer zone of hyperemia.
Damage from burn trauma causes irreversible necrosis
in the area known as the zone of coagulation. As a result
of indirect damage resulting from thermal trauma, a zone
of stasis forms around the zone of coagulation. The zone
of stasis is an important component of the burn injury
because it may progress to coagulation necrosis after the
first 24 h following the trauma, before which it is vital and
can be salvaged. Therefore, by salvaging the zone of stasis,
the progression of burn wound-related degeneration can
be prevented, and this has been one of the main foci of
burn-related research for many years. Many agents and
methods have been used to salvage the stasis zone (2–6).
* Correspondence: uraloglu@hotmail.com

Better understanding of the pathological process in this
zone may provide important targets for procedures aiming
at preventing progression of burn injuries.
Low molecular weight heparins (LMWHs) are an
important new class of anticoagulants with several
advantageous over their ancestor, unfractioned
heparin, for the prophylaxis and treatment of venous
thromboembolism (7).
The prominent role of microthromboembolism
and associated hypoxia and necrosis in the zone of
stasis following burn injury, and effective clinical use of
LMWHs, makes these anticoagulants an attractive option
for preventing deepening of the wound by salvaging the
zone of stasis.
The purpose of this study was to investigate the
potential effect of enoxaparin, a LMWH, on salvaging the
zone of stasis in an experimental rat burn model.
2. Materials and methods
The study protocols were approved by the Local Ethics
Committee on Animal Research. Adult female Sprague-
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Dawley rats (250–300 g) were housed in standard
conditions (21 ± 1 °C and a 12:12 light–dark cycle) with
free access to water and standard animal chow. Sixteen rats
were randomly divided into two groups (n = 8 in each):
group 1 (the LMWH group) and group 2 (the saline group).
The dorsal skin was shaved under general anesthesia
(50 mg/kg ketamine, Ketalar, Pfizer and 10 mg/kg xylazine
Rompun, Bayer), and burn wounds were induced using the
comb model (8). A rectangular brass comb consisting of
four rows (10 × 20 mm) and three interspaces (5 × 20 mm)
was heated in boiling water and held to the skin surface
for 20 s (Figure 1). This was performed without applying
any additional pressure to the comb beyond that of gravity.
The rats were kept in individual cages after the burn injury.
Thirty minutes after the induction of burn wounds, 1.5 mg/
kg enoxaparin (Clexane, Sanofi, Aventis) was administered
subcutaneously into the inguinal area distant to the burn
injury site in the LMWH group rats, and the same dose
was repeated daily for the next 7 days, starting 24 h from
the first injection. The saline group was given the same
amount of saline via the same route. The rats were kept in
individual cages in the postburn period. The functional
capillary density (FCD) evaluation was performed daily,
and all rats were sacrificed for histological evaluation on
day 8, postburn.
2.1. Outcome of necrosis
The outcome of necrosis was measured grossly. This was
done by measuring each interspace with complete necrosis
(turning black) and those of a viable nature. The percentage
represented by the viable area was calculated by comparing
these with the percentage of interspaces with complete
necrosis.
2.2. Functional capillary density evaluation
FCD evaluations were performed using an orthogonal
polarization spectral (OPS) imaging device equipped

Figure 1. Application of comb to induce burn. A rectangular
brass comb was heated in boiling water and held to the skin
surface for 20 s.
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with a video microscope (Cytoscan A/R, Cytometrics,
Philadelphia, PA, USA), and all data were saved in AVI
format (Sony VGN-FW 230J/H) and analyzed with this
software (9–11). Burn areas were examined daily, for
7 days, by recording microcirculation over at least 20 s
(Figure 2). The measurements were done in the stasis zone,
between coagulation zones. Video recordings were made
for each and transferred from the OPS imaging device
to computer software (CapiScope; Lekam Medical Ltd.,
Devon, UK) for further evaluation. All FCD measurements
were performed using this software (9). FCD was defined
as the length of erythrocyte-perfused capillaries (cm) per
observation area (cm2). The observer measuring FCD was
blinded to the treatment administered.
2.3. Histological evaluation
Once the procedures were complete, the animals were
sacrificed, and a full-thickness skin biopsy was taken
from each. These were fixed with 10% formalin solution,
dehydrated with alcohol, and embedded in paraffin blocks.
The specimens were stained with hematoxylin and eosin
(H&E) and Masson’s trichrome stain and analyzed under
light microscopy. Macrophage and polymorphonuclear
leukocyte (PMN) density, fibroblast proliferation,
and angiogenesis were analyzed as the percentage of
40×-magnified burn zone images using Analysis 5

Figure 2. Vascularity was evaluated using orthogonal polarization
spectral (OPS) imaging.
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software (Olympus Soft Imaging Solutions, Munster,
Germany). The results were expressed as the number of
cells in each microscopic area. The investigator conducting
the histological examinations was blinded to the groups.
2.4. Statistical analysis
Statistical analyses were performed using SPSS for
Windows (SPSS Inc., Chicago, IL, USA). All quantitative
data were analyzed using the Mann–Whitney U and
Friedman tests, where appropriate. A P-value < 0.05 was
regarded as significant.
3. Results
3.1. Macroscopic assessment
No obvious complications occurred during the research
period in terms of saline and LMWH injection, and no
mortality was encountered. Ratios of surviving areas in
the zone of stasis were calculated with translucent graph
paper on day 7. In the saline group most of the interspace
areas were necrotic in appearance on day 7 (Figure 3a),
while in the LMWH group most of the interspace areas
appeared to be viable (Figure 3b). The mean surviving

Figure 3a. Saline group, day 7.

area was 70.40 ± 11% in the LMWH group and 55.10 ±
4.01% in the saline group. The difference was statistically
significant (P = 0.001).
3.1. Functional capillary density
FCD values worsened progressively throughout the
experiment in the saline group, but remained relatively
constant in the LMWH group. When the FCD values were
compared between the groups, LMWH was observed to
provide a time-dependent favorable effect. The difference
between the groups was statistically significant from
day 4 and remained so throughout the remainder of the
experimental period (Figure 4; Table 1).
3.2. Histological assessment
The mean macrophage infiltration values in the LMWH
and saline groups were 16.5 ± 3.7 (n = 8) and 13.1 ± 3.1
(n = 8), respectively (P = 0.082, Table 2). PMN density
was lower in the saline group (mean 7.4 ± 2.6) than in the
LMWH group (mean 8.6 ± 3.7), but the difference was not
statistically significant (P = 0.597).
Fibroblast proliferation was significantly higher in
the LMWH group (mean 77.0 ± 23.6) than in the saline

Figure 3b. LMWH group, day 7.
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Figure 4. Time course of functional capillary density values in the low molecular weight
heparin and saline groups.
Table 1. The effect of low molecular weight heparin on functional capillary density. Different superscript letters indicate significant
differences (P < 0.001) in mean values. Mean values with the same superscript letters (a or b) are not statistically significant different.
Functional capillary density
Day 1

Day 2

Day 3

Day 4

Day 5

Day 6

Day 7

LMWH

22.4 ± 2.0a

22.3 ± 2.1a

23.4 ± 2.3a

21.7 ± 2.6a

22.6 ± 2.2a

22.5 ± 2.0a

22.2 ± 2.3a

Saline

23.0 ± 1.6a

21.9 ± 2.4a

21.6 ± 2.7a

20.1 ± 2.0a

19.5 ± 1.2b

18.6 ± 1.7b

18.8 ± 1.5b

P-value

0.400

0.529

0.059

0.431

0.003

0.003

0.009

group (mean 54.5 ± 14.9, p = 0.035). Angiogenesis was
significantly higher in the LMWH group (mean 15.0 ± 3.4)
compared to the saline group (mean 10.5 ± 3.3) (P = 0.023)
(Figure 5; Table 2).
4. Discussion
Inflammatory mediators generated from the inflammatory
cells through thermal action can impact adversely on burn
wounds (12–15). Hemodynamic alterations and additional
infection may also lead to further progression of burn
wound necrosis (14,16). Following burn trauma, the zone
of stasis can be supported and progressive tissue necrosis
thereby prevented by salvaging this zone using agents with
potential beneficial effects on perfusion in the affected area
(17–20).
Progressive burn-mediated damage resulting from
impaired circulation may occur in the zone of stasis or the
zone of ischemia. It has been postulated that individual
and/or combined effects of hypercoagulability, neutrophil
occlusion, erythrocyte plugging, vasoconstriction, and
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edema mediate the reduced blood flow in the zone of
stasis, and that the process thus leads to hypoxia and free
radical-mediated injury (21). Insufficiency of the blood
supply is a key element in the process among those factors
causing progression of burn wound and delays in healing
(15,22).
Thrombus formation is one of the main mechanisms
involved in compromised local circulation in the zone of
stasis, since thrombus-mediated vessel occlusion has been
histologically documented in burn injuries (23,24).
LMWHs are derived from unfractionated heparin
through deaminative hydrolysis of heparin. They
exhibit inhibitory action on active factor X with weak
antithrombin activity and are effective in the prevention
of vascular thrombosis, as well as possessing the
advantage of a lower risk of hemorrhage, a side-effect
that is relatively unpredictable with heparin use (25).
LMWHs have been successfully used for many years
for the prevention and treatment of a variety of clinical
conditions, including venous thromboembolism (7),
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Figure 5. Histological appearances of the zone of stasis in the low molecular weight heparin (LMWH) and saline groups. 5a. LMWH
group. 5b. Saline group.
Table 2. The effect of low molecular weight heparin on local responses to burn injury.
Angiogenesis

Fibroblast

Macrophage density

PMN

LMWH group

15.0 ± 3.4

77.0 ± 23.6

16.5 ± 3.7

8.6 ± 3.7

Saline group

10.5 ± 3.3

54.5 ± 14.9

13.1 ± 3.1

7.4 ± 2.6

P-value

0.023

0.035

0.082

0.597

acute coronary syndrome, and coronary and peripheral
percutaneous revascularization. Controlled clinical trials
have also confirmed that LMWH is superior to heparin in
the prevention of arterial thrombosis (26).
Heparin-induced thrombocytopenia (HIT) is
a potentially destroying immune mediated adverse
drug reaction during the emergence of antibodies that
activate platelets in the presence of heparin. Despite
thrombocytopenia, bleeding is rare; HIT is associated
with thromboembolic complications. Arterial thrombosis
occurs more frequently than venous thrombosis in
HIT patients. The incidence is approximately 5% with
unfractioned heparin and 0.5% with LMWH (27).
To date, some anticoagulants, steroid and nonsteroid
antiinflammatory drugs, antiaggregants, thrombolytic
agents, hormones, and antioxidants were investigated in
experimental and clinic studies for salvaging the zone of
stasis (2–5,17,28–36). Very few of them have been used in
clinical practice, but LMWH may be used routinely.
Some of the evidence from clinical and animal studies
supports the antiinflammatory role heparin and heparinrelated derivatives (37,40). It is now well established that
LMWH has many superior advantages, such as a lower
risk of hemorrhage and a positive effect on the serum lipid
profile. In the first hours after a traumatic injury such as
burns, the inflammatory response includes increased

nitric oxide (NO) production. NO has a protagonist role
in inflammatory diseases. Increased NO after burning
combines with peroxynitrite-forming superoxide anion
(39). Free radicals and lipid peroxidation mediated injury
causes significant cell damage in burn trauma. Burn
patients were treated with and without LMWH to provide
evidence that LMWH has nitric oxygen synthase (NOS)
reducing activity and LMWH was observed to be more
effective than heparin in the treatment of burn patients.
This was proved by colorimetric and immunohistological
studies (39,40).
In the light of these properties, antithrombotic agents
exhibit a high potential indication for salvaging the zone
of stasis in burn injuries. However, to the best of our
knowledge, this has never been tested in salvaging zones
of stasis, and this deficiency inspired the current research.
OPS imaging is a technique based on the optical
filtration of polarized light absorbed by hemoglobin
(41). This method permits direct in vivo real-time
imaging of the capillary network and visualization of the
microcirculation in tissues including burned skin (42) and
provides qualitative and quantitative information about
perfusion because the capillaries are easily visible and red
blood cells can be tracked in real time (43,44). This imaging
technique has been validated for the measurement of
different microcirculatory parameters, in particular FCD,
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as a parameter of dermal perfusion. Burn injury causes
acute thrombosis and occlusion of the dermal vasculature.
A vascular response also occurs in the area bordering the
injury site (8). OPS has been demonstrated to be sensitive in
detecting damaged and nondamaged tissues (42). We used
OPS imaging to measure the microcirculation in the stasis
zone in this study. LMWH effectively prevented a decrease
in FCD values compared to the saline group, in which
FCD values declined after burn injury. The prevention of
a decrease in FCD values is a positive parameter of burn
wound healing.
Based on histological findings, the increased
macrophage infiltration, angiogenesis, and fibroblast
proliferation observed in the LMWH group indicate
that LMWH had a positive impact on the burn wound
healing process in the zone of stasis. Many mediators,
such as cytokines and interleukins, are released from
the macrophages resulting from fibroblast activation.
Proliferation of fibroblast is associated with increased
collagen accumulation. We also determined improved
angiogenesis in the LMWH group, a process that facilitates
burn wound healing. Oremus et al. (37) performed a
large series systematic review to assess the evidence
for or against using heparin in the treatment of burn
injury. Although they determined a general decrease in
mortality, improvements in burn wound healing and relief
of burn pain, they concluded that most of the studies
they reviewed were poorly designed and that there was
insufficient evidence to support the use of heparin in the
treatment of burn injuries. They also indicated that the
increased risk of bleeding should be considered in patients
receiving heparin. In agreement with previous clinical
and experimental studies (37,45), we think that the use of
unfractioned heparin may have beneficial effects on burn
wound healing, but may also heighten the risk of bleeding.

Many agents and drug have previously been used
to salvage the zone of stasis. Our experimental study is
the first to investigate the potential effect of the LMWH
enoxaparin on salvaging the zone of stasis after burn
trauma. Salvaging this zone following burn trauma has been
the subject of many experimental studies testing various
different agents, although most of the experimentally
promising agents remain to be clinically validated (3–5).
From that perspective, enoxaparin is a clinically proven
agent for anticoagulation and is of greater potential use in
burn injury cases. LMWH may also provide an additional
advantage since moderately and severely burned patients
are relatively immobile and hemodynamically unstable,
and are prone to hypercoagulation and associated risks,
including thromboembolism.
In parallel to the great diversity in terms of skin
anatomy and histology, there are also significant differences
in stages of burn injury development and wound healing
among different mammals, including mice, rats, rabbits,
pigs, and humans (46). While thrombosis occurs early in
rats (8,47), this phenomenon occurs later in humans and
pigs (48,49). In the early period in humans and pigs, the
vessels in the zone of stasis are plugged with red blood cells,
but no thrombosis occurs. This may explain why heparin
has proved to be ineffective in human studies (37). Once
the framework of burn injury has been established in the
inflammatory phase, the subsequent phases are initiated.
These differences need to be taken into consideration
when evaluating the translational potential of research
from animal models, including ours.
In conclusion, our study demonstrates that LMWH
helps salvage the zone of stasis in a rat comb burn model.
However, whether these results will translate into larger
animals and humans remains unclear and will require
further testing.
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